Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer

PaperCitations, authors & open-access status

Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 76 citations, 2021 year and bronze oa status.

76
Citations
2021
Year
bronze
OA Status

Related on ScholarIQ

Xiaoyan Ma
Author
Clinical Cancer Research
Journal
PARP inhibition in cancer therapy
Topic
PARP inhibition in cancer therapy
Topic
Ovarian cancer diagnosis and treatment
Topic
Advanced Breast Cancer Therapies
Topic
470M+ articles · free account